You are here: All Products  > LianBio Stops China Trial of Liver Cancer Drug After Helsinn Asks FDA to Withdraw Approval

LianBio Stops China Trial of Liver Cancer Drug After Helsinn Asks FDA to Withdraw Approval

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products